Potassium Perchlorate
» Potassium Perchlorate contains not less than 99.0 percent and not more than 100.5 percent of KClO4, calculated on the dried basis.
Caution: Great care should be taken in handling Potassium Perchlorate in solution or in the dry state, as explosions may occur if it is brought into contact with organic or other readily oxidizable substances.
Packaging and storage—
Preserve in well-closed containers.
Identification—
A:
Ignite a small portion of a solution (1 in 10) on a platinum wire in a nonluminous flame: a transient violet color is imparted to the flame.
B:
Add a few drops of methylene blue solution (1 in 1000) to the solution (1 in 10): a violet-colored precipitate is formed.
pH 
791
:
between 5.0 and 6.5, in a 0.1 M solution.
791:
between 5.0 and 6.5, in a 0.1 M solution.
Loss on drying 731—
Dry it over silica gel for 12 hours: it loses not more than 0.5% of its weight.
731—
Dry it over silica gel for 12 hours: it loses not more than 0.5% of its weight.
Insoluble substances—
Dissolve 20 g in 150 mL of warm water, pass through a tared medium-porosity filtering crucible, and wash with three 50-mL portions of warm water. Dry the residue at 105
for 3 hours: the weight of the residue does not exceed 1 mg (0.005%).
for 3 hours: the weight of the residue does not exceed 1 mg (0.005%).
Chloride 221—
A 5.0-g portion shows no more chloride than corresponds to 0.20 mL of 0.020 N hydrochloric acid (0.003%).
221—
A 5.0-g portion shows no more chloride than corresponds to 0.20 mL of 0.020 N hydrochloric acid (0.003%).
Heavy metals, Method I 231:
0.001%.
231:
0.001%.
Limit of sodium—
Ignite a small portion of a solution (1 in 10) on a platinum wire in a nonluminous flame: no pronounced yellow color is imparted to the flame.
Assay—
Mobile phase—
Transfer 16.6 g of phthalic acid to a 100-mL volumetric flask, dissolve in and dilute with methanol to volume, and mix. Transfer 10.0 mL of this solution to a 1000-mL flask, dilute with water to volume, and mix. Adjust with about 450 mg of lithium hydroxide to a pH of 4.5, filter, and degas.
Standard preparation—
Transfer about 50 mg of potassium perchlorate, accurately weighed, to a 50-mL volumetric flask, dilute with water to volume, and mix. Transfer 10.0 mL of this solution to a 100-mL volumetric flask, dilute with water to volume, and mix to obtain a solution having a known concentration of about 0.1 mg per mL.
Assay preparation—
Using about 50 mg of Potassium Perchlorate, accurately weighed, proceed as directed for the Standard preparation.
Chromatographic system
(see Chromatography 621)—The liquid chromatograph is equipped with a conductivity detector and a 4.6-mm × 7.5-cm column that contains 6-µm packing L23. The flow rate is about 1.2 mL per minute. Chromatograph the Standard preparation, and record the peak responses as directed for Procedure: the tailing factor is not more than 1.5; and the relative standard deviation for replicate injections is not more than 2.0%.
621)—The liquid chromatograph is equipped with a conductivity detector and a 4.6-mm × 7.5-cm column that contains 6-µm packing L23. The flow rate is about 1.2 mL per minute. Chromatograph the Standard preparation, and record the peak responses as directed for Procedure: the tailing factor is not more than 1.5; and the relative standard deviation for replicate injections is not more than 2.0%.
Procedure—
Separately inject equal volumes (about 50 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the quantity, in mg, of KClO4 in the portion of Potassium Perchlorate taken by the formula:
500C(rU / rS)
in which C is the concentration, in mg per mL, of potassium perchlorate in the Standard preparation; and rU and rS are the peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information—
Please check for your question in the FAQs before contacting USP.
Chromatographic Column—
| Topic/Question | Contact | Expert Committee |
| Monograph | Ian DeVeau, Ph.D.
Director, Veterinary Drugs and Radiopharmaceuticals 1-301-816-8178 |
(RMI05) Radiopharmaceuticals and Medical Imaging Agents 05 |
USP32–NF27 Page 3351
Pharmacopeial Forum: Volume No. 32(2) Page 364
Chromatographic columns text is not derived from, and not part of, USP 32 or NF 27.